WELCOME TO
BSG LIVE’25

 This promotional symposium is organised and funded by Pfizer Ltd, intended for UK healthcare professionals, and will include reference to Pfizer medicines relevant to the agenda topics. Company products will be discussed.

This promotional symposium by Pfizer Ltd, “S1P Receptor Modulators: Clinical experience reflections and how to incorporate them into clinical practice”, will explore the role of S1P receptor modulators in the UC landscape. This event will address unmet need, and clinical trials through to actual treatment, incorporating key insights from clinical studies. Attendees will benefit from practical guidance on patient management, alongside real-world case studies illustrating successful integration into clinical pathways. By synthesising data and experiences, the symposium aims to equip healthcare professionals with the necessary knowledge when considering the introduction of S1Ps into their clinical practice.

Symposium Agenda- 40 mins -13.30pm-14.10pm Room- Boisdale

Prof. Daniel Gaya-Consultant Gastroenterologist at Glasgow Royal Infirmary

Introduction and unmet need from clinical trials to actual treatment, presenting key insights from clinical studies

Dr Shameer Mehta-Consultant Gastroenterologist at Royal London Hospital

Real world case studies

Angela Chana-Lead IBD Pharmacist at St Mark’s National Bowel Hospital, London

Practical guidance and patient management

Panel discussion/Q&A

Please note that, under the law and the ABPI Code of Practice, Pfizer may only promote its medicines to members of the healthcare professions and other relevant decision makers. Therefore, no unqualified person (e.g. students, non-medical spouses/partners/family members) may be invited to or attend Pfizer promotional meetings.

For UK Healthcare Professionals only.

PP-V1A-GBR-0435
Date of preparation April 2025